MBNL1 and facioscapulohumeral muscular dystrophy: To determine whether the microtranscriptome changes are specific to MBNL1 deficiency or are a consequence of muscle pathology (e.g. myotonia or muscle dystrophy), we assessed whether similar miRNA changes were observed in a mouse model of facioscapulohumeral muscular dystrophy (FSHD).